Choose Language
Select a language for news translation.
Written by Robert Izquierdo for The Motley Fool -> The VanEck Pharmaceutical ETF provides a lower expense ratio and a more substantial dividend yield than the …
Anthropic launched Claude Science to help scientists develop drugs using AI. This move expands the company beyond coding tools and joins other tech giants in d…
Research published in the British Medical Journal (BMJ) has found that a United Kingdom-United States pharmaceutical deal could cause 229,000 excess deaths as …
The nation’s top pharmacy benefit manager (PBM) lobbying group is going on the offensive, stepping up its advocacy efforts against the pharmaceutical industry …
Legend Biotech and BioNTech are likely buyout targets due to their profitable therapies and strong pipelines. Their potential acquisitions matter because big p…
The U.S. is investigating Germany’s drug pricing system, claiming it forces American patients to overpay for medications while Germany keeps costs low at home.…



















